A Phase I/II Clinical Study of SHR-1681 for Injection in Patients With Advanced Solid Tumors
Clinical trial NCT06737731 · RECRUITING
Trial details
- NCT number
- NCT06737731
- Sponsor
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-21
- Primary completion
- 2026-11-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.